Question

    Which of the following is a molecule being researched under ICMR’s Phase 1 Clinical Trials for CAR-T cell therapy?

    A Zika vaccine Correct Answer Incorrect Answer
    B Influenza vaccine Correct Answer Incorrect Answer
    C CAR-T cell therapy for chronic lymphocytic leukemia Correct Answer Incorrect Answer
    D Multiple myeloma Correct Answer Incorrect Answer
    E Covaxin Correct Answer Incorrect Answer

    Solution

    ICMR’s First-in-Human Clinical Trials include research on CAR-T cell therapy for chronic lymphocytic leukemia in collaboration with ImmunoACT.

    Practice Next